SCHEMBL14923453

SCHEMBL14923453

N#Cc1cc(F)c(N[C@@H](CN2C(=O)c3ccccc3C2=O)c2ccccc2)nc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 4/20 0.37
▸ KHK P50053 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAP3K8 P41279 2/20 0.35
▸ BCHE P06276 3/20 0.35
▸ PGK1 P00558 1/20 0.35
▸ CYP2D6 P10635 2/20 0.34
▸ SLC6A2 P23975 2/20 0.34
▸ SLC6A4 P31645 2/20 0.34
▸ NOS2 P35228 2/20 0.34
▸ GLA P06280 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ PIK3CD O00329 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14911299 0.85 ALDH1A1 (0.40) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL14911298 0.85 ALDH1A1 (0.40) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL16165769 0.84 ACHE (0.40) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL15081454 0.84 ACHE (0.40) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL14911213 0.84 ALDH1A1 (0.39) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL14911214 0.84 ALDH1A1 (0.39) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL14928385 0.83 ALDH1A1 (0.37) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL14923707 0.83 PGK1 (0.38) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL14923600 0.82 ALDH1A1 (0.38) ACHEKHKALDH1A1CYP1A2CYP2C9
SCHEMBL14928332 0.82 ACHE (0.40) ACHEKHKALDH1A1SMN1; SMN2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK ACHE 4592/4885KHK 2008/4885ALDH1A1 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback